Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
...
21
22
23
24
25
26
27
28
29
...
99
100
Next >
Vertex Pharmaceuticals Stock: Analyst Estimates & Ratings
November 18, 2025
Via
Barchart.com
Exposures
Product Safety
StoryBoom Partners with Filmmaker James Dalessandro to Empower Future Storytellers
November 18, 2025
Via
Binary News Network
Topics
Product Recall
Exposures
Legal
Product Safety
Honda Recalls Over 256,000 Accord Hybrid Vehicles Over Software Issue
↗
November 18, 2025
Via
Benzinga
Topics
Product Recall
Tickers
F
GM
HMC
TM
Exposures
Legal
Product Safety
Invivyd Stock Hits 19-Month High As Public Offering Lands Days After Point72, Janus Henderson Reveal Big Stakes
↗
November 17, 2025
Via
Stocktwits
Tickers
IVVD
Exposures
COVID-19
Product Safety
3 Reasons We’re Fans of DexCom (DXCM)
November 17, 2025
Via
StockStory
Tickers
DXCM
Exposures
Product Safety
Congress to Convene Critical Hearing on AI Chatbots: Balancing Innovation with Public Safety
November 17, 2025
Via
TokenRing AI
Topics
Artificial Intelligence
Tickers
GOOGL
MSFT
Exposures
Artificial Intelligence
Product Safety
Beyond Aesthetics: Medical AI Prioritizes Reliability and Accuracy for Clinical Trust
November 17, 2025
Via
TokenRing AI
Topics
Artificial Intelligence
Tickers
GEHC
GOOGL
MSFT
NVDA
Exposures
Artificial Intelligence
Product Safety
'My Theory ... Was That Someday a Nun Would Go Bad' – Buffett Recalls Fingerprinting Nuns While Recovering From an Appendectomy
↗
November 17, 2025
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Revenue Expansion, Regulatory Momentum, and a Leadership Position in the $750 Million Suicidal Depression: NRx Pharmaceuticals (N A S D A Q: NRXP)
November 17, 2025
Via
PRLog
Exposures
Product Safety
Three Revenue-Generating Facilities in Florida Plus Six More by Year-End in Expanding $750 Million Market Suicidal Depression Market: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
November 17, 2025
Via
Get News
Tickers
NRXP
Exposures
Product Safety
Medcrypt Achieves 100% FDA Submission Approval Rate and Launches Security Intelligence to Help Mature Medical Device Cybersecurity Program
November 17, 2025
Via
PRUnderground
Exposures
Product Safety
Why Did TNXP Stock Jump 10% Today?
↗
November 17, 2025
Via
Stocktwits
Tickers
TNXP
Exposures
Product Safety
CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces That Cytokinetics, Incorporated Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit
November 17, 2025
Via
NewMediaWire
Topics
Fraud
Lawsuit
Tickers
CYTK
Exposures
Financial
Legal
Product Safety
CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces That Cytokinetics, Incorporated Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit
November 17, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Tickers
CYTK
Exposures
Financial
Legal
Product Safety
Celcuity Analyst No Longer Bullish Despite Breast Cancer Therapy Application
↗
November 17, 2025
Via
Benzinga
Tickers
CELC
Exposures
Product Safety
Omeros (OMER) Q3 2025 Earnings Call Transcript
↗
November 17, 2025
Via
The Motley Fool
Topics
Derivatives
Earnings
Tickers
NVO
OMER
Exposures
Derivatives
Financial
Product Safety
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports Q3 Results and Advances Lead Candidate TPI 287 Toward Phase 2 GBM Study
November 17, 2025
Via
Investor Brand Network
Tickers
CNSP
Exposures
Product Safety
BioMedNewsBreaks — NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Reports Q3 Results and Advances NRX-100 and NRX-101 Regulatory Programs
November 17, 2025
Via
Investor Brand Network
Tickers
NRXP
Exposures
Product Safety
Cytokinetics, Incorporated Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before November 17, 2025 to Discuss Your Rights - CYTK
November 17, 2025
Via
TheNewswire.com
Topics
Earnings
Fraud
Lawsuit
Tickers
CYTK
Exposures
Financial
Legal
Product Safety
Cytokinetics, Incorporated Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before November 17, 2025 to Discuss Your Rights - CYTK
November 17, 2025
Via
NewMediaWire
Topics
Earnings
Fraud
Lawsuit
Tickers
CYTK
Exposures
Financial
Legal
Product Safety
aTyr Pharma, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - ATYR
November 17, 2025
Via
NewMediaWire
Topics
Fraud
Lawsuit
Tickers
ATYR
Exposures
Financial
Legal
Product Safety
aTyr Pharma, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - ATYR
November 17, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Tickers
ATYR
Exposures
Financial
Legal
Product Safety
OS Therapies Reports Third Quarter 2025 Financial Results and Provides Business Update
November 17, 2025
Via
Newsfile
Tickers
OSTX
Exposures
Product Safety
Is Robinhood Stock a Buy Now?
↗
November 17, 2025
Via
The Motley Fool
Topics
Bankruptcy
Economy
Initial Public Offering
Tickers
HOOD
IBKR
SCHW
Exposures
COVID-19
Economy
Financial
From Immigrant to Industry Leader: How Julia Biro Built WeDoSkin into Canada’s Fastest-Growing Skincare Retailer
November 17, 2025
Via
Press Release Distribution Service
Topics
Product Recall
Exposures
Legal
Product Safety
Sarepta Stock Slides Premarket After New FDA Warning Shrinks Market For Its $3.2M DMD Gene Therapy
↗
November 17, 2025
Via
Stocktwits
Topics
Death
Tickers
SRPT
Exposures
Death
Product Safety
2 of Wall Street’s Favorite Stocks on Our Watchlist and 1 Facing Headwinds
November 16, 2025
Via
StockStory
Tickers
DPZ
DXCM
TGLS
Exposures
Product Safety
Anavex Retail Traders See Silver Lining In EMA Committee Postpones Alzheimer’s Drug Verdict: Delay 'Actually A Positive Sign'
↗
November 16, 2025
Via
Stocktwits
Tickers
AVXL
Exposures
Product Safety
uniQure N.V. Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm
November 15, 2025
Via
NewMediaWire
Topics
Fraud
Tickers
QURE
Exposures
Legal
Product Safety
uniQure N.V. Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm
November 15, 2025
Via
TheNewswire.com
Topics
Fraud
Tickers
QURE
Exposures
Legal
Product Safety
< Previous
1
2
...
21
22
23
24
25
26
27
28
29
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today